Andy Pasternak
Director · Context Therapeutics Inc.
Individual
- 2026
- Jun 26, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andy Pasternak files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- HRTG GPE, LLC - $50.00M in KARD purchases and sales in the last 12 months
- Paul L. Berns - $20.00M in KARD purchases and sales in the last 12 months
- ARCH Venture Partners XIII, LLC - $20.00M in KARD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andy Pasternak?
Andy Pasternak is a corporate insider, tracked as Director of Context Therapeutics Inc. (CNTX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Andy Pasternak last file a Form 4?
The most recent primary Form 4 on record is dated 26 June 2026, one of 2 filings going back to 2026.
